Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction

AbstractAims. Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently

Saved in:

Bibliographic Details
Main Authors:	Kahles, Florian (Author) , Biener, Moritz (Author) , Giannitsis, Evangelos (Author) , Katus, Hugo (Author)
Format:	Article (Journal)
Language:	English
Published:	2020
In:	European heart journal Year: 2019, Volume: 41, Issue: 7, Pages: 882-889
ISSN:	1522-9645
DOI:	10.1093/eurheartj/ehz728
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehz728 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/41/7/882/5588525
Author Notes:	Florian Kahles, Marcia V. Rückbeil, Robert W. Mertens, Ann C. Foldenauer, Maria C. Arrivas, Julia Moellmann, Corinna Lebherz, Moritz Biener, Evangelos Giannitsis, Hugo A. Katus, Nikolaus Marx, and Michael Lehrke

Description
Summary:	AbstractAims. Glucagon-like peptide 1 (GLP-1) is a gut incretin hormone inducing post-prandial insulin secretion. Glucagon-like peptide 1 levels were recently
Item Description:	Online publish-ahead-of-print: 16 October 2019 Gesehen am 31.03.2020
Physical Description:	Online Resource
ISSN:	1522-9645
DOI:	10.1093/eurheartj/ehz728